Ovarian stimulation in the treatment of infertility is far from physio
logical because patients and their ovaries are exposed to high concent
rations of gonadotropins. Many studies have focused on the two most co
mmon side-effects of ovarian stimulation-ie, hyperstimulation and mult
iple pregnancy. We describe 12 patients in whom granulosa-cell tumour
was discovered after ovarian stimulation treatment with clomiphene cit
rate and/or gonadotropins. Although we cannot prove a causal link betw
een the tumour and the medication, investigations in animals have show
n a relation between gonadotropin exposition and the development of gr
anulosa-cell tumours. The possible relation of ovarian stimulation and
granulosa-cell tumours in human beings has not been published before.
We postulate three explanations for this finding; first, the granulos
a-cell tumour is present in the ovary, waiting for a hormonal trigger;
second, increased follicle stimulating hormone concentrations are onc
ogenic to granulosa cell; and third, the onset of the granulosa-cell t
umour during ovarian stimulation is coincidental. We recommend that ov
arian stimulation is done only if there is a valid indication after pr
oper assessment of the ovaries, and that women who have had ovarian st
imulation are followed for longer than at present.